Tempus unveils cloud-based data and analytics platform

By The Science Advisory Board staff writers

May 20, 2021 -- Artificial intelligence (AI) developer Tempus announced the launch of Lens, a cloud-based data and analytics platform.

The Lens platform is designed to provide scientists and researchers across biotechnology and pharmaceutical companies with short-term, on-demand access to more than 35 petabytes of de-identified clinical and molecular datasets. The platform includes AI analytical tools intended to accelerate drug discovery and development.

The platform enables users to access, analyze, and build upon Tempus' library of data in an optimized environment equipped with the tools needed to extract insights in minutes, the company stated in a release.


Copyright © 2021 scienceboard.net
 


Email Address:

First Name:

Last Name:

Learn about ScienceBoard

Get the latest life sciences research and industry news, delivered straight to your inbox, for free.

Why subscribe?

ScienceBoard is uniquely focused on the business of research, addressing the biggest problems that the biomedical industry face. You’ll get breaking news, events coverage, and deep dives into the science that drives innovation, delivered to your inbox daily.

I have read and agree to the privacy policy and terms of service and wish to opt-in for ScienceBoard.net.